Aion Therapeutic Inc.
ANTCF
$0.0055
-$0.001-15.39%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.96M | -4.66M | -4.64M | -813.90K | -694.00K |
| Total Depreciation and Amortization | 72.90K | 52.00K | 31.10K | 11.20K | 4.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.76M | 3.74M | 3.72M | 186.00K | 80.60K |
| Change in Net Operating Assets | 200.70K | 29.90K | 260.20K | 699.90K | 423.10K |
| Cash from Operations | -922.50K | -846.20K | -624.80K | 83.20K | -185.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 100.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.30K | -165.50K | -214.10K | -214.10K | -196.80K |
| Cash from Investing | -17.30K | -165.50K | -214.10K | -214.10K | -96.50K |
| Total Debt Issued | 450.20K | 450.20K | 35.00K | 36.00K | 19.40K |
| Total Debt Repaid | -244.10K | -79.10K | -32.90K | -12.30K | -141.80K |
| Issuance of Common Stock | 992.00K | 1.14M | 1.09M | 542.50K | 542.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.60K | 25.60K | 25.60K | 25.90K | -- |
| Cash from Financing | 897.90K | 1.13M | 827.50K | 438.30K | 310.70K |
| Foreign Exchange rate Adjustments | 111.60K | -79.20K | 63.30K | -48.30K | -37.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.50K | 35.90K | 51.90K | 259.10K | -8.90K |
